In Brief: FDA deputy commissioner of operations
This article was originally published in The Tan Sheet
Executive Summary
FDA deputy commissioner of operations: Michael Friedman, MD, associate director of the Cancer Therapy Evaluation Program at the National Cancer Institute in Bethesda, will assume the position of FDA deputy commissioner of operations on October 1. The job was left vacant when Linda Suydam, who held the office on an interim basis, departed Sept. 1 to become associate VP for planning and development at the University of New Mexico in Albuquerque ("The Tan Sheet" Sept. 4, In Brief)...